Department of Health - Abu Dhabi

The Department of Health – Abu Dhabi (DoH) is the regulator and strategic lead for Abu Dhabi's healthcare life-science (HLS) sector, and the stratgic lead of the HELM Cluster (an integrated platform spanning genomics, digital health, advanced therapies, clinical trials, and biomanufacturing). Abu Dhabi offers global partners a sovereign-backed environment combining the world's largest genomics program (900K+ genomes), nationally connected health data, accelerated regulatory pathways (8–15 day clinical trial approvals), strategic capital commitments to biotech infrastructure, and targeted incentive packages for R&D, manufacturing, and commercialization. Positioned as a neutral, competitive destination at the frontier of bioconvergence where genomics, AI, and clinical delivery converge at scale. Abu Dhabi is building the next global hub for healthcare life-science innovation and growth.